These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 32951880)

  • 1. Desvenlafaxine withdrawal serotonergic syndrome in a newborn.
    Sánchez Malo MJ; Hidalgo Sanz J; Curto Simón B
    Med Clin (Barc); 2021 Jul; 157(2):93-94. PubMed ID: 32951880
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of 50 and 100 mg desvenlafaxine versus placebo on sexual function in patients with major depressive disorder: a meta-analysis.
    Clayton AH; Hwang E; Kornstein SG; Tourian KA; Cheng RF; Abraham L; Mele L; Boucher M
    Int Clin Psychopharmacol; 2015 Nov; 30(6):307-15. PubMed ID: 26230270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An integrated analysis of the efficacy and safety of desvenlafaxine in the treatment of major depressive disorder.
    Carrasco JL; Kornstein SG; McIntyre RS; Fayyad R; Prieto R; Salas M; Mackell J; Boucher M
    Int Clin Psychopharmacol; 2016 May; 31(3):134-46. PubMed ID: 26895080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of desvenlafaxine on blood pressure in patients treated for major depressive disorder: a pooled analysis.
    Thase ME; Fayyad R; Cheng RF; Guico-Pabia CJ; Sporn J; Boucher M; Tourian KA
    Curr Med Res Opin; 2015 Apr; 31(4):809-20. PubMed ID: 25758058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Desvenlafaxine Versus Placebo in the Treatment of Children and Adolescents with Major Depressive Disorder.
    Atkinson S; Lubaczewski S; Ramaker S; England RD; Wajsbrot DB; Abbas R; Findling RL
    J Child Adolesc Psychopharmacol; 2018 Feb; 28(1):55-65. PubMed ID: 29185786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of desvenlafaxine 50 mg and 100 mg on energy and lassitude in patients with major depressive disorder: A pooled analysis.
    Lam RW; Wajsbrot DB; Meier E; Pappadopulos E; Mackell JA; Boucher M
    J Psychopharmacol; 2017 Sep; 31(9):1204-1214. PubMed ID: 28718346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Desvenlafaxine Versus Placebo in a Fluoxetine-Referenced Study of Children and Adolescents with Major Depressive Disorder.
    Weihs KL; Murphy W; Abbas R; Chiles D; England RD; Ramaker S; Wajsbrot DB
    J Child Adolesc Psychopharmacol; 2018 Feb; 28(1):36-46. PubMed ID: 29189044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, double-blind, placebo-controlled trial of desvenlafaxine succinate in adult outpatients with major depressive disorder.
    Liebowitz MR; Yeung PP; Entsuah R
    J Clin Psychiatry; 2007 Nov; 68(11):1663-72. PubMed ID: 18052559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of desvenlafaxine on cognitive functioning in employed outpatients with major depressive disorder: a substudy of a randomized, double-blind, placebo-controlled trial.
    Reddy S; Fayyad R; Edgar CJ; Guico-Pabia CJ; Wesnes K
    J Psychopharmacol; 2016 Jun; 30(6):559-67. PubMed ID: 27009044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of metabolic syndrome and thyroid hormone on efficacy of desvenlafaxine 50 and 100 mg/d in major depressive disorder.
    McIntyre RS; Fayyad R; Mackell JA; Boucher M
    Curr Med Res Opin; 2016; 32(3):587-99. PubMed ID: 26709542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Withdrawal-Emergent Dyskinesia Following Abrupt Discontinuation of Desvenlafaxine.
    Wu L; Gerdts EA; Alam A
    Prim Care Companion CNS Disord; 2019 Jan; 21(1):. PubMed ID: 30664338
    [No Abstract]   [Full Text] [Related]  

  • 12. A double-blind, placebo-controlled study of the efficacy and safety of desvenlafaxine succinate in the treatment of major depressive disorder.
    DeMartinis NA; Yeung PP; Entsuah R; Manley AL
    J Clin Psychiatry; 2007 May; 68(5):677-88. PubMed ID: 17503976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety, Tolerability, and Efficacy of Desvenlafaxine in Children and Adolescents with Major Depressive Disorder: Results from Two Open-Label Extension Trials.
    Atkinson S; Thurman L; Ramaker S; Buckley G; Jones SR; England R; Wajsbrot D
    CNS Spectr; 2019 Oct; 24(5):496-506. PubMed ID: 30419989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined use of desvenlafaxine and electroconvulsive therapy.
    Martín-Larrégola M; Gómez-Arnau J; Rodríguez-Salgado B; Dolengevich-Segal H
    Actas Esp Psiquiatr; 2016; 44(2):79-82. PubMed ID: 27099215
    [No Abstract]   [Full Text] [Related]  

  • 15. Improvements in quality of life with desvenlafaxine 50mg/d vs placebo in employed adults with major depressive disorder.
    Endicott J; Lam RW; Hsu MA; Fayyad R; Boucher M; Guico-Pabia CJ
    J Affect Disord; 2014 Sep; 166():307-14. PubMed ID: 25012446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Desvenlafaxine Versus Placebo in a Fluoxetine-Referenced Study of Children and Adolescents with Major Depressive Disorder: Design, Definitions, and Ongoing Challenges for Child and Adolescent Psychopharmacology Research.
    Strawn JR; Croarkin PE
    J Child Adolesc Psychopharmacol; 2018 Jun; 28(5):363. PubMed ID: 29620924
    [No Abstract]   [Full Text] [Related]  

  • 17. An evaluation of sexual functioning in employed outpatients with major depressive disorder treated with desvenlafaxine 50 mg or placebo.
    Clayton AH; Reddy S; Focht K; Musgnung J; Fayyad R
    J Sex Med; 2013 Mar; 10(3):768-76. PubMed ID: 22905811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pooled analysis of the efficacy of desvenlafaxine for the treatment of major depressive disorder in perimenopausal and postmenopausal women.
    Kornstein SG; Clayton AH; Bao W; Guico-Pabia CJ
    J Womens Health (Larchmt); 2015 Apr; 24(4):281-90. PubMed ID: 25860107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical utility of desvenlafaxine 50 mg/d for treating MDD: a review of two randomized placebo-controlled trials for the practicing physician.
    Reddy S; Kane C; Pitrosky B; Musgnung J; Ninan PT; Guico-Pabia CJ
    Curr Med Res Opin; 2010 Jan; 26(1):139-50. PubMed ID: 19919295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A placebo-controlled study evaluating the efficacy and safety of flexible-dose desvenlafaxine treatment in outpatients with major depressive disorder.
    Feiger AD; Tourian KA; Rosas GR; Padmanabhan SK
    CNS Spectr; 2009 Jan; 14(1):41-50. PubMed ID: 19169187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.